Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging

Area of Science:

• Oncology
• Medical Imaging
• Radiation Oncology

Background:

• Magnetic-resonance spectroscopic imaging (MRSI) can differentiate cancerous from normal prostate tissue based on metabolic ratios.
• Prostate cancer treatment planning can benefit from incorporating MRSI data to target malignant regions more effectively.

Purpose of the Study:

• To develop and evaluate a novel brachytherapy treatment-planning optimization module using integer programming.
• To integrate MRSI data with intraoperative ultrasound for precise dose escalation to intraprostatic tumor deposits.

Main Methods:

• MRSI was performed on a patient with Gleason 7 prostate cancer to identify high-risk regions.
• A novel registration method mapped MRSI data onto ultrasound images.
• An integer-programming technique optimized seed distribution for permanent brachytherapy implants.
• The system was tested for dose escalation feasibility to MRSI-positive voxels while sparing surrounding tissues.

Main Results:

• The MRSI-optimized plan successfully delivered 120% of the 144 Gy prescription to MRSI-positive voxels.
• Dose constraints for the prostate and urethra were maintained.
• The optimized plan demonstrated a superior estimated tumor control probability (TCP) compared to standard brachytherapy planning.
• TCP enhancement was more significant for smaller tumor volumes.

Conclusions:

• The developed brachytherapy optimization system is feasible for (125)I permanent prostate implants.
• MRS-guided dose optimization shows potential for improving outcomes in aggressive, organ-confined prostate cancers.
• The magnitude of TCP improvement is dependent on tumor localization and MRSI detection efficiency.